PharmaEssentia Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	7,154	6,032	3,383	4,381	2,477	719
Market Cap Growth	2.76%	78.30%	-22.77%	76.88%	244.49%	0.07%
Enterprise Value	6,600	5,449	2,800	4,274	2,462	612
Last Close Price	19.30	18.14	10.20	-	-	-
PE Ratio	53.25	69.04	-	-	-	-
PS Ratio	18.52	21.03	22.44	49.91	118.91	44.34
PB Ratio	8.60	7.45	4.78	11.85	18.37	6.30
P/TBV Ratio	8.67	7.53	4.84	12.08	19.50	6.68
P/FCF Ratio	84.57	121.51	-	-	-	-
P/OCF Ratio	59.29	80.38	-	-	-	-
EV/Sales Ratio	17.86	19.00	18.58	48.69	118.21	37.73
EV/EBITDA Ratio	58.04	100.14	-	-	-	-
EV/EBIT Ratio	63.16	106.51	-	-	-	-
EV/FCF Ratio	78.03	109.75	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.05	0.13	0.13	0.17
Debt / EBITDA Ratio	0.21	0.47	-	-	-	-
Debt / FCF Ratio	0.30	0.57	-	-	-	-
Asset Turnover	0.43	0.33	0.24	0.27	0.11	0.13
Inventory Turnover	1.22	0.86	0.48	0.83	0.60	1.15
Quick Ratio	6.45	9.34	9.86	4.37	2.80	3.37
Current Ratio	6.83	9.94	10.64	5.24	3.49	3.82
Return on Equity (ROE)	17.21%	11.54%	-3.46%	-16.77%	-68.81%	-63.10%
Return on Assets (ROA)	7.68%	3.72%	-5.61%	-11.77%	-30.08%	-25.26%
Return on Invested Capital (ROIC)	43.99%	26.72%	-43.05%	-85.59%	-210.08%	-130.09%
Return on Capital Employed (ROCE)	12.80%	6.10%	-7.60%	-15.90%	-59.00%	-38.60%
Earnings Yield	1.88%	1.45%	-0.54%	-0.96%	-3.60%	-7.88%
FCF Yield	1.18%	0.82%	-1.74%	-1.26%	-3.24%	-6.22%
Dividend Yield	0.08%	0.16%	-	-	-	-
Buyback Yield / Dilution	-0.44%	-3.59%	-13.47%	-9.24%	-7.39%	-10.55%
Total Shareholder Return	-0.35%	-3.43%	-13.47%	-9.24%	-7.39%	-10.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.